The expression of all cytokines was significantly reduced in the groups treated with 0.02 mM of verteporfin and 0.2 mM of verteporfin compared to the AD control group (Figure 3), except for Il17 expression in the 0.02 mM of verteporfin-treated group (Figure 3G). This evidence concerns the gene IL17A and Alzheimer disease.